Statement by CDC Director Thomas R. Frieden, M.D., M.P.H., on Early End of HPTN 052 Study
CDC welcomes the report today from NIH that early HIV treatment can dramatically reduce the risk that an HIV-positive person will transmit the virus to their heterosexual partner. The study, known as HPTN 052, showed that early initiation of anti-retroviral therapy (ART) for HIV-positive people who were heterosexual led to a dramatic reduction in HIV transmission to the HIV-uninfected partner.
CDC welcomes the report today from NIH that early HIV treatment can dramatically reduce the risk that an HIV-positive person will transmit the virus to their heterosexual partner. The study, known as HPTN 052, showed that early initiation of anti-retroviral therapy (ART) for HIV-positive people who were heterosexual led to a dramatic reduction in HIV transmission to the HIV-uninfected partner.
This Coalition transmission preserves metadata, trust context, and source routing for a Public Intelligence item from CDC. The complete article remains with the original publisher.
Content handling is marked as Public Domain. Use the source article link for the full report, updates, corrections, and publisher-controlled context.
Key Points
- Published by CDC.
- Categorized as Public Intelligence.
- Source handling: Verified Source.
- Rights posture: Public Domain.
- Follow the source article for the complete original report.